Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsUrl

    Url

    Jump to

    • Sun Pharma rises 4% ahead of Q2 nos, Taro's earnings strong

      Taro's sales grew 28 percent year-on-year. Its operating profits grew faster at 46 percent led by 740 basis points margin expansion. Religare has hiked its target price to Rs 725.

    • What to expect from Sun Pharma in Q4

      Sun Pharmaceutical Indusries' fourth quarter revenues may rise by 26 percent year-on-year to Rs 2,946 crore during the March quarter.

    • Sun Pharma to continue holding stake in Taro, says VP Fin

      Uday Baldota, Senior Vice President-Finance & Accounts, Sun Pharma said the company will continue to hold stake in Taro despite their termination of the merger agreement.

    • Storyboard: Twitter buzzes with anti-govt messages

      This week on Storyboard, CNBC-TV18 brings you details of the debate that sprung up post the government's block of several URLs.

    • 80% Of Mistyped URLs Lead To Typosquatting Sites: Study

      Sophos study investigates every possible one-character typo of Facebook, Google, Twitter, Microsoft, Apple and Sophos homepage

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347